Literature DB >> 28506192

The Expanding Prominence of Toxic Leukoencephalopathy.

Christopher M Filley1, Brice V McConnell1, C Alan Anderson1.   

Abstract

Toxic leukoencephalopathy (TL) is a disorder of brain white matter caused by exposure to leukotoxic agents. Magnetic resonance imaging (MRI) can readily identify this syndrome, and, together with diffusion tensor imaging, MRI continues to offer important insights into its nature. Since the first formal description of TL in 2001, many new leukotoxic disorders have been recognized, and the range of leukotoxins has expanded to include more therapeutic drugs, drugs of abuse, and environmental insults. While the understanding of pathophysiology remains incomplete, TL is increasingly common in clinical practice, and the potential long-term cognitive sequelae of toxic white matter injury merit attention.

Entities:  

Keywords:  Cognitive Disorders; Drug/Substance Abuse; Epidemiology of Neuropsychiatric Disorders; Imaging Techniques; Toxicological CNS Disorders

Mesh:

Year:  2017        PMID: 28506192     DOI: 10.1176/appi.neuropsych.17010006

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  5 in total

1.  Brain Reserve in a Case of Cognitive Resilience to Severe Leukoaraiosis.

Authors:  Dana M Szeles; Nicholas J Milano; Hunter J Moss; Maria Vittoria Spampinato; Jens H Jensen; Andreana Benitez
Journal:  J Int Neuropsychol Soc       Date:  2020-06-16       Impact factor: 2.892

Review 2.  Neurotoxic Effects of Childhood Cancer Therapy and Its Potential Neurocognitive Impact.

Authors:  Nicholas S Phillips; Elizabeth S Duke; Hannah-Lise T Schofield; Nicole J Ullrich
Journal:  J Clin Oncol       Date:  2021-04-22       Impact factor: 50.717

3.  Full Recovery From Cocaine-Induced Toxic Leukoencephalopathy: Emphasizing the Role of Neuroinflammation and Brain Edema.

Authors:  Edward C Mader; Alexander B Ramos; Roberto A Cruz; Lionel A Branch
Journal:  J Investig Med High Impact Case Rep       Date:  2019 Jan-Dec

4.  Intracortical myelin in individuals with alcohol use disorder: An initial proof-of-concept study.

Authors:  Vanessa Morris; Nicholas Bock; Luciano Minuzzi; James MacKillop; Michael Amlung
Journal:  Brain Behav       Date:  2022-09-14       Impact factor: 3.405

5.  Implications for White Matter Vulnerability to Anti-interleukin-6 Receptor Antibody Treatment.

Authors:  Daisuke Kato
Journal:  Intern Med       Date:  2020-10-07       Impact factor: 1.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.